Pharmacokinetics of a THIOMAB™ antibody drug conjugate (TDC): DMUC4064A in a phase 1 study with platinum-resistant ovarian cancer

被引：1
|
作者：
Garg, Amit
She, Gaohong
Donatello, Ian
Kagedal, Matts
Leipold, Douglas D.
Saad, Ola
Liu, Joyce
Moore, Kathleen
Hamilton, Erika
Burris, Howard
Wang, Judy
Birrer, Michael
Humke, Eric
Girish, Sandhya
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT092
引用
收藏
页数：2
相关论文
共 50 条
  • [41] CHEMOSENSITIVITY AFTER ANTI-PD-1 ANTIBODY NIVOLUMAB FOR PLATINUM-RESISTANT RECURRENT OVARIAN CANCER
    Inayama, Y.
    Hamanishi, J.
    Matsumura, N.
    Murakami, R.
    Abiko, K.
    Yamaguchi, K.
    Baba, T.
    Horie, K.
    Konishi, I.
    Mandai, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 709 - 709
  • [42] A phase II study of irinotecan and docetaxel in patients with platinum-resistant relapsed epithelial ovarian cancer
    Matsumoto, T.
    Hiura, M.
    Oshita, T.
    Hirata, E.
    Shiroyama, Y.
    Wroblewski, J.
    Yokoyama, T.
    Nogawa, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer
    Pignata, S
    Varriale, E
    Casella, G
    Iodice, F
    De Placido, G
    Perrone, F
    Tramontana, F
    Ricchi, P
    De Vivo, R
    Costanzo, R
    Vernaglia, A
    Tramontana, S
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 613 - 616
  • [44] Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer
    Thejeswar, N.
    Goenka, L.
    Dubashi, B.
    Kayal, S.
    Jayanthi, M.
    Barathi, D.
    Ganesan, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S1510 - S1510
  • [45] Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer
    Walsh, Christine S.
    Kamrava, Mitchell
    Rogatko, Andre
    Kim, Sungjin
    Li, Andrew
    Cass, Ilana
    Karlan, Beth
    Rimel, Bobbie J.
    PLOS ONE, 2021, 16 (06):
  • [46] A phase I study of the safety and pharmacokinetics of DNIB0600A, an anti-NaPi2b antibody-drug-conjugate (ADC), in patients (pts) with non- small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (OC).
    Gordon, Michael S.
    Gerber, David E.
    Infante, Jeffrey R.
    Xu, Jian
    Shames, David S.
    Choi, Younjeong
    Kahn, Robert S.
    Lin, Kedan
    Wood, Katie
    Maslyar, Daniel J.
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] PHASE 1 DOSE-ESCALATION STUDY OF STRO-002, AN ANTI-FOLATE RECEPTOR ALPHA (FRα) ANTIBODY DRUG CONJUGATE (ADC), IN PATIENTS WITH ADVANCED PLATINUM-RESISTANT/REFRACTORY EPITHELIAL OVARIAN CANCER (OC)
    Naumann, R.
    Braiteh, F.
    Diaz, J.
    Hamilton, E.
    Diab, S.
    Schilder, R.
    Moroney, J.
    Martin, L.
    Uyar, D.
    O'Malley, D.
    Penson, R.
    DiLea, C.
    Palumbo, M.
    DeAlmeida, V.
    Berman, C.
    Matheny, S.
    Molina, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A61 - A61
  • [48] Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: A phase IIa study of the AGO Study Group
    Baumann, K.
    Pfisterer, J.
    Wimberger, P.
    Burchardi, N.
    Kurzeder, C.
    du Bois, A.
    Loibl, S.
    Sehouli, J.
    Huober, J.
    Schmalfeldt, B.
    Vergote, I.
    Lueck, H. J.
    Wagner, U.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 27 - 32
  • [49] Sacituzumab Govitecan, a Novel Antibody-Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma
    Faltas, Bishoy
    Goldenberg, David M.
    Ocean, Allyson J.
    Govindan, Serengulam V.
    Wilhelm, Francois
    Sharkey, Robert M.
    Hajdenberg, Julio
    Hodes, Gillian
    Nanus, David M.
    Tagawa, Scott T.
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : E75 - E79
  • [50] Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study
    Hamilton, Erika
    O'Malley, David M.
    O'Cearbhaill, Roisin
    Cristea, Mihaela
    Fleming, Gini F.
    Tariq, Bilal
    Fong, Abraham
    French, Dorothy
    Rossi, Michael
    Brickman, Daniel
    Moore, Kathleen
    GYNECOLOGIC ONCOLOGY, 2020, 158 (03) : 640 - 645
12345